Concepedia

Publication | Open Access

Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 Expression

DOIFull Paper Access

58

Citations

28

References

2018

Year

Ammar Muhammad, Eva C Coopmans, Federico Gatto, Sanne Franck, J. A. M. J. L. Janssen, Aart Jan van der Lely, Leo J. Hofland, Sebastian Neggers
The Journal of Clinical Endocrinology & Metabolism

Abstract

In a cohort of patients partially responsive to SRLs, the IGF-I-lowering effects of PAS-LAR treatment correlated with the effect of SRL treatment and seemed to be mainly driven by SSTR2 expression instead of SSTR5.

References

YearCitations

Page 1